We have identified an 85 kb BAC clone, 346J21, that carries a cell senescence gene (SEN16), previously mapped to 16q24.3. Transfer and retention of 346J21 in breast cancer cell lines leads to growth arrest after 8-10 cell doublings, accompanied by the appearance of characteristic senescent cell morphology and senescence-associated acid b-galactosidase activity. Loss of transferred BAC results in reversion to the immortal growth phenotype of the parental cancer cell lines. BAC 346J21 restores senescence in the human breast cancer cell lines, MCF.7 and MDA-MB468, and the rat mammary tumor cell line LA7, but not in the human glioblastoma cell line T98G. We postulate that inactivation of both copies of SEN16 is required for the immortalization of breast epithelial cells at an early stage of tumorigenesis. Positional mapping of 346J21 shows that SEN16 is distinct from other candidate tumor suppressor genes reported at 16q24.
Introduction
Normal diploid human cells undergo replicative senescence after a finite number of divisions in culture (Hayflick and Moorhead, 1961; Hayflick, 1974) . In contrast, cells cultured from many tumors can proliferate indefinitely. Cellular senescence is a genetically controlled dominant program and is characterized by distinct alterations in cell phenotypes. Senescencerelated constraints on cell division are postulated as anticancer and escape from senescence is an important step in neoplastic transformation (Campisi, 2000 (Campisi, , 2001 .
The dominant nature of cellular senescence has provided an opportunity to identify senescence loci by microcell transfer of individual human chromosomes into immortal cell lines (Ohmura et al., 1995; Bertram et al., 1999; Tominaga et al., 2002) . Applying this approach, we have previously identified cell senescence loci on human chromosomes 6 and 16 (Sandhu et al., 1994 (Sandhu et al., , 1996 Reddy et al., 1999 Reddy et al., , 2000 . Chromosome 16 is of particular interest because an abundance of evidence points to the presence of multiple tumor suppressor genes on the long arm of 16. Rearrangements of 16q have frequently been documented in a number of human cancers, including breast (Lindblom et al., 1993; CletonJansen et al., 1994; Tsuda et al., 1994; Driouch et al., 1997; Hansen et al., 1998) , ovarian (Hansen et al., 2002) , prostate (Suzuki et al., 1996; Godfrey et al., 1997) , lung (Sato et al., 1998) and hepatocellular carcinomas (Bando et al., 2000; Balsara et al., 2001) . Loss of chromosome 16 was also observed in SV40 immortalized human fibroblasts (Hubbard-Smith et al., 1992) . Frequent loss of heterozygosity (LOH) of chromosome 16 markers has identified 16q22.1, 16q23.2-q24.1 and 16q24.3 as commonly deleted regions in breast, liver and prostate cancer (Cleton-Jansen et al., 2001) . Analysis of 21 established breast tumor cell lines also revealed deletions predominantly located at 16q22.1 and 16q24.3 . 16q alterations have been observed in breast tumors with little or no abnormality in the rest of the chromosome complement, implying that they may be early events in breast carcinogenesis. Cytogenetic analysis of E1A-transformed nontumorigenic prostate epithelial cell lines revealed a consistent deletion on 16q (Chin et al., 1998) , indicating that 16q loss is concomitant with cellular immortalization. A high incidence of 16q LOH observed in ductal carcinoma in situ (DCIS), a pre-invasive state of ductal breast cancer, also implicates 16q as an early event in the etiology of breast cancer (Lakhani et al., 1995; Radford et al., 1995; Vos et al., 1999) . Frequent LOH observed at three different sites on 16q, associated with many different type of cancers, suggests that it may harbor more than one tumor suppressor gene.
Microcell-mediated transfer of normal chromosome 16 or 16q22-qter restored replicative senescence in immortal cell lines derived from breast, ovarian and prostate tumors and SV40-transformed cells (Reddy et al., 1999) . While restoration of senescence, following chromosome transfer into immortal cells, implies the presence of senescence genes on the donor chromosome, reversion of senescent cells to immortal growth can result from inactivation of senescence gene(s) due to a mutation or deletion. Analysis for the loss of DNA markers, in revertant clones originating from independent senescent microcell hybrids, mapped the SEN16 locus within a 3 cM genetic interval at 16q24.3 (Reddy et al., 1999) . The precise positional information allowed us to identify candidate Yeast Artificial Chromosome (YAC) clones, which may carry the SEN16 locus. The functional testing of individual YAC clones, located at 16q24.3, led to the identification of a single 360 kb YAC that carries the SEN16 gene (Reddy et al., 2000) . This paper reports the identification of an 85 kb BAC clone that carries the SEN16 gene, by functional complementation of immortal breast tumor cells.
Results

Construction of a BAC contig at the SEN16 locus
We used two approaches to identify BAC clones from the SEN16 locus: screening of a PCR-ready human BAC library and searching the human genome database. In all, 25 STS markers, previously mapped to the SEN16 locus by deletion analysis (Reddy et al., 1999) , were used to identify corresponding BAC clones by library screen or database search. A total of 35 BACs identified by these methods were purchased from Invitrogen, CA, USA. These BACs were tested to confirm the expected markers and other adjacent markers. These data allowed us to confirm overlapping BAC clones and assemble a preliminary physical map corresponding to a 3 cM genetic interval between markers D16S520 and D16S413 at 16q24.3. Our preliminary contig map was interrupted with several gaps. Next, BACs flanking each gap were partially sequenced at both ends of the insert. PCR primer pairs from each end sequence (Table 1) were used to rescreen the human BAC library. BAC clones identified in the second screen were tested with BAC end markers as well as with other mapped markers to confirm gap closure. Some overlaps were identified by homology search of BAC end sequences in the genome databases. These data allowed us to complete a detailed physical map for a 1.3 Mb genomic region at 16q24.3, comprised of 17 BAC clones (Figure 1 ). The relative order of markers and BAC clones was confirmed and updated by comparison with the available draft sequence of chromosome 16 (http://www.ncbi.nlm.nih. gov/mapview/maps.cgi). Each BAC insert was sized by pulsed field gel electrophoresis (PFGE) and fingerprinted after digestion with HindIII.
Four of the BAC clones in Figure 1 overlay YAC792E1, which was previously shown to induce senescence in immortal breast tumor cell lines (Reddy et al, 2000) . The 150 kb insert of 344A17 and the slightly larger insert of 178L8 both carry all seven STS markers mapped to the 360 kb insert of YAC792E1. The 85 kb insert of 346J21 carries four markers from the left side of YAC792E1, which are associated with senescence activity (Reddy et al., 2000) .
Transfer of BACs into immortal cells
To test for SEN16 function in immortal tumor cell lines, BACs were first retrofitted with a neo marker to permit selection of transfected cells in G418. BAC retrofitting was accomplished by excising the human insert from the parent vector with NotI and recloning into pJMOx166, a BAC vector that carries the neo marker. BACs 344A17, 178L8, and 106D4 proved difficult to retrofit because of multiple internal NotI restriction sites, but 346J21 has no internal NotI sites and was successfully retrofitted. Two BACs from the contig, 924B9 and 276J15, which do not overlap YAC792E1, were chosen as negative controls for functional tests, and were also retrofitted successfully. The integrity of retrofitted BACs was confirmed by PCR for human markers as well as by HindIII fingerprinting of the insert (data not shown). The origin of the human inserts in retrofitted 346J21 and 924B9 was tested by FISH. Retrofitted 346J21 showed a single hybridization signal at 16q24.3 (Figure 2 ), but 924B9 is chimeric and lit up chromosome 13 as well as 16 (data not shown).
Purified retrofitted DNA from BACs 346J21, 924B9, and 276J15 was introduced into human and rodent immortal tumor cell lines using lipofection or electroporation. The empty retrofitting vector was included as an additional negative control. The recipient cell lines for BAC transfer experiments included MCF.7 and MDA-MB468 (human breast tumor cell lines), T98G (human glioblastoma cell line), LA7 (rat mammary tumor cell line), and A9 (mouse connective tissue cell line). Previous studies showed that introduction of a normal human chromosome 16 restores senescence in MCF, MDA-MB468, and LA7 cells, but not in T98G and A9 cells (Reddy et al., 1999) . BAC transfer colonies were maintained in G418 throughout each experiment, unless otherwise noted. The number and phenotype of colonies recovered from each transfection experiment are recorded in Table 2 .
BAC 346J21 restores senescence in rat mammary tumor cells
Transfer of retrofitted BAC 346J21 into LA7 rat mammary tumor cells produced three types of colonies: 12 senescent colonies, eight parental type colonies, and 15 colonies comprised of a mixture of senescent and parental type cells (Table 2) . Senescent LA7/346J21 colonies were comprised entirely of enlarged, flattened, vacuolated cells (Figure 3 ) with an initial doubling time of 30-40 h, which increased progressively until complete growth arrest. At this stage, each colony contained 300-400 cells. After 4 weeks, one of the senescent colonies was stained to confirm the presence of senescenceassociated b-galactosidase (SA-b-gal) activity (Figure 3 ). Half the remaining senescent colonies were harvested by trypsinization and pooled for PCR analysis. Five other senescent colonies were maintained in G418 until they peeled off the plate 1-2 months after plating. Peeled cells from each colony were collected for PCR analysis. DNA from the senescent cells harvested by trypsinization (LA346senpool), and from each of the peeled senescent colonies (e.g. LA346sen1), was positive for the neo marker as well as four chromosome 16 markers present on 346J21 (Table 3) .
In contrast, cells in parental type colonies were morphologically indistinguishable from the parental LA7 cells and grew with the same 15-18 h doubling time as the parental cells. After 2 weeks, parental colonies were transferred to fresh plates and passaged in G418 for 2 months with no decrease in growth rate. PCR analysis of six of these clones (e.g. LA346par1) confirmed the presence of the neo marker, but failed to detect four chromosome 16 markers present on 346J21 (Table 3) .
In all, 15 colonies were observed to consist of a mixed population of cells with a senescent morphology, which stained positive for SA-b-gal, interspersed with cells of parental morphology, which stained negative for SAb-gal. As expected, passaging of mixed clones resulted in progressive dilution of the senescent-type cells. A pooled Functional identification of SEN16 GP Kaur et al mixed cell population was shown to be positive for the neo marker as well as for four chromosome 16 markers located on BAC 346J21. Subcloning of these colonies in G418 gave rise to pure parental clones that retained the neo marker but had lost most or all of the chromosome 16 markers (e.g. Table 3 , LA346R1 and R2). 
Functional identification of SEN16 GP Kaur et al
We conclude that transfer and retention of 346J21 induces senescence in immortal LA7 rat mammary tumor cells. G418-resistant parental colonies arise from the retention of incomplete BAC 346J21 DNA following transfer into LA7 cells. Mixed colonies arise from transfer of intact 346J21, followed by reversion due to subsequent loss of part of 346J21 from one or more cells in the colony.
BAC 346J21 restores senescence in human breast tumor cells
Transfer of retrofitted 346J21 into MCF.7 cells also produced three types of colonies. A total of 72 colonies obtained included 28 senescent colonies, six parental type colonies, and 38 mixed colonies. Transfer of retrofitted 346J21 into MDA-MB468 cells gave rise to two types of colonies, which included 30 senescent and 48 parental type colonies (Table 2 ). Senescent colonies in both human cell lines consisted of enlarged, flattened, vacuolated cells (Figure 3 ) that grew with an initial doubling time of 90-96 h and ceased to divide after 4-6 weeks. These growth-arrested colonies contained 300-1000 cells that stained positive for SA-b-gal ( Figure 3 ) and peeled off the plates after an additional 3-6 weeks. In contrast, parental-type colonies of MCF.7/346J21 and MDA-MB468/346J21 were indistinguishable from the parental cell line and did not stain for SA-b-gal activity.
Retention of intact 346J21 DNA in MCF.7/346J21 or MDA-MB468/346J21 cells could not be confirmed due to lack of polymorphic differences in the DNA markers between the BAC and the recipient cells, but both parental and senescent colonies tested positive for the retention of neo gene, as expected (Table 3) . However, when some of the colonies consisting only of senescent cells were transferred to nonselective medium lacking G418, after 4-6 weeks they were overgrown by a segregant cell population that had growth and morphological characteristics similar to parental MCF.7 cells. Parental type segregants were unable to grow when recultured in G418 medium, confirming the loss of BAC DNA.
In parallel experiments, we also transferred BACs 924B9 and the vector pJMOx166, into LA7 and MCF.7, and MDA-MB468 and BAC 276J15 into MCF.7 and LA7 cells. These experiments produced only parentaltype colonies (Table 2, Figure 3 ). PCR analysis of parental-type MCF.7/924B9 colonies, for the polymorphic marker D16S476 and for neo, showed that the donor BAC 924B9 was retained in each case. Similarly, PCR analysis of LA7/924B9 and LA7/ 276J15 clones for markers confirmed the retention of the BAC in these colonies (data not shown). These negative controls indicate that the human DNA sequence in 346J21 is responsible for induction of senescence in MCF.7, MDA-MB468 and LA7 cells.
BAC 346J21 has no effect on T98G human glioblastoma or mouse A9 connective tissue cells
Transfer of retrofitted 346J21 into T98G and A9 cells produced 35 and 46 colonies ( Table 2 ). All T98G/346J21 and A9/346J21 clones displayed the parental phenotype, with morphology and growth characteristics indistinguishable from T98G or A9 cells. PCR analysis of parental A9 clones confirmed retention of 346J21 markers. As expected, transfer of 924B9 into T98G and A9 cells also produced only parental colonies.
Discussion
Applying a functional approach, we have identified a BAC, 346J21, that restores a normal cell growth phenotype and restricts replicative potential in human breast and rat mammary tumor cell lines. Starting with an intact chromosome (Reddy et al., 1999 (Reddy et al., , 2000 , we progressively narrowed the position of SEN16 to the 85 kb insert of 346J21. Cells that retain the transferred BAC are able to undergo 8-10 rounds of cell division before terminal growth arrest. This is sufficient to observe the formation of colonies carrying the transfected BAC and to test for retention of BAC markers in heterospecific host cells. Growth retardation is accompanied by the appearance of differentiated cell morphology and the senescence-associated b-galactosidase marker. The phenotype observed in 346J21 transfer clones is identical to the phenotype obtained after the transfer of an intact normal chromosome 16 into the same cell lines. BAC 346J21 also shows the same specificity as chromosome 16, restoring senescence in MCF.7, MDA-MB468, and LA7, but not in T98G and A9 cells. Growth arrest in BAC transfer clones is irreversible as long as the BAC DNA is retained by the cells, but is completely reversed upon loss of a part or all of the transfected human DNA sequences, giving rise to revertant or segregant colonies that are indistinguishable from the parental cell line. The simplest explanation of our complementation data is that 346J21 carries a gene, SEN16, that plays an essential role in a pathway leading to replicative senescence in mammary epithelial cells, which is inactivated on both copies of chromosome 16 in immortal human breast and rat mammary tumor cell lines. We postulate that inactivation of SEN16 is an early event in cancer progression, permitting clonal expansion and accumulation of additional mutations. Chromosome transfer experiments suggest that the same gene may be implicated in the immortalization of ovarian and prostate epithelial cells (Reddy et al., 1999) . BAC 346J21 has no effect on some other immortal cell lines such as T98G and A9, suggesting that immortalization of these cell lines involved inactivation of other genes in the same pathway or in a different pathway leading to senescence.
Chromosome 16q has been extensively scrutinized by different methods such as comparative genomic hybridization (CGH), LOH, and sequence analysis in search of tumor suppressor genes (Whitmore et al., 1998a; Powell et al., 2002; Vivienne Watson et al., 2004) . High incidence of LOH reported at three different regions of 16q, in several different types of cancers, suggest that more than one tumor suppressor genes may be located on 16q. A number of potential candidate tumor suppressor genes for breast cancer (Bednarek et al., 2000; Kochetkova et al., 2002) , prostate cancer (Vivienne Watson et al., 2004) , and hepatocellular carcinoma (Saffroy et al., 2002) have been identified by virtue of differential expression or deletion in tumor vs normal tissue.
The BAC mapping and transfer studies reported here, together with previously reported YAC transfer studies (Reddy et al., 2000) , establish that SEN16 is distinct from six other candidate tumor suppressor genes that have been reported at16q24 (Figure 4) . The WWOX gene, which encodes an oxidoreductase-like protein that may play a role in apoptosis, is underexpressed in many breast cancer cell lines, and upon re-expression inhibits tumorigenicity and anchorage-independent growth; it maps at the fragile site FRA16D between D16S516 and D16S518 about 8 Mb centromeric from 346J21 (Bednarek et al., 2000 (Bednarek et al., , 2001 . The 17-b-HSD2 gene, which encodes an enzyme involved in estrogen metabolism and is frequently deleted in human hepatocellular carcinoma (Huang et al., 2001) , has been mapped between D16S505 and D16S422, approximately 5 Mb centromeric from BAC 346J21. CDH13, which encodes a cadherin-like protein that may be involved in cell surface adhesion and may be either up-or downregulated in tumor cells, maps between D16S422 and D16S402 (Kawakami et al., 1999; Chalmers et al., 2001) , about 3.7 Mb centromeric from BAC 346J21. The WFDC1 gene (Larsen et al., 2000) , which encodes the secreted ps20 protein and is growth inhibitory in prostate carcinoma cells, maps between D16S402 and D16S3061, about 3 Mb centromeric from BAC 346J21. The CBFA2T3 gene, which encodes a member of the ETO family of proteins that may be involved in transcriptional regulation, is underexpressed in breast cancer cells and upon reexpression inhibits cell growth ; it maps between D16S413 and D16S3026, about 1 Mb telomeric from BAC 346J21. The GAS11 gene, the human homolog of a growth arrest-specific mouse gene, maps near D16S303 close to the telomere (Whitmore et al., 1998b) , about 2 Mb telomeric from BAC 346J21. A physical map of these genes relative to 346J21 is given in Figure 4 .
Computer analysis of the DNA sequence around 16q24 predicts 10-11 unigene clusters on BAC 178L8 , several of which are also present on 346J21 which overlays 178L8 (see Figure 1) . Detailed characterization of transcripts from BAC 346J21 will allow us to confirm the identity of SEN16 and explore its integrity and expression in tumor cells and in normal cells as they approach senescence.
Materials and methods
Cell lines and culture conditions
Cell lines used in these studies included MCF.7 and MDA-MB468 (human breast tumor), T98G (human brain tumor), LA7 (rat mammary tumor), and mouse A9 cells. The normal human cell line GM03468A (Human Mutant Cell Repository, Camden, NJ, USA) was used for the phenotypic comparison of replicative senescence. All cell lines were routinely cultured at 371C in a 7.5% CO 2 /air incubator in DF12 medium supplemented with 10% fetal bovine serum. Base medium was supplemented with G418 (400 mg/ml) for the selection and propagation of BAC transfer colonies. Colonies were refed at 3-day intervals.
Identification of BAC clones
PCR ready DNA pools of a human BAC library, comprised of 150 K clones (Invitrogen, CA, USA), were screened with primers for 25 STS markers (shown in Figure 1 ) mapped at the SEN16 locus (Reddy et al., 1999) . End sequences obtained from some BACs were used either for rescreening of the BAC library, using the PCR primers listed in Table 1 , or for a homology search of the human genome database. The BAC clones thus identified were purchased from Invitrogen, CA, USA. Individual BAC clones were propagated in LB medium containing 12.5 mg/ ml chloramphenicol and subcloned to generate single-cell clonal populations. 
Retrofitting of BAC clones
BAC clones were retrofitted to incorporate a neo gene for the selection of mammalian cells in G418. Retrofitting was carried out using the procedure and the plasmid described by Mejia and Monaco (1997) . Briefly, the human DNA insert in a BAC clone was released by digestion with NotI and fractionated by PFGE. Human DNA purified from the agarose gels was then ligated with Not1 linearized and dephosphorylated pJMOx166 vector DNA (Mejia and Monaco, 1997) . This vector carries a cat gene to select for chloramphenicol resistance in Escherichia coli cells and a neo gene for selection of mammalian cells in G418. Ligated DNA was transformed into E. coli DH10B cells and the transformation mix was plated on LB medium containing 30 mg/ml kanamycin and 20 mg/ml chloramphenicol. The resulting transformant clones were analysed for the presence of STS markers and by PFGE to confirm the presence and the size of the human insert.
Transfer of BAC DNA into immortal tumor cells DNA, for each retrofitted BAC, was isolated from 500 ml cultures by alkaline lysis and purified through Qiagen 500-ml tip columns. Purified BAC DNA was introduced into immortal recipient cells using lipofection or electroporation methods. For lipofection, recipient cells (5 Â 10 5 /100 mm plate) were seeded in 100 mm tissue culture dishes, 24 h prior to transfection. BAC DNA (10 mg) was mixed with 300 ml of lipotaxi reagent (Stratagene) and added to the medium in a monolayer of recipient cells. After 12 h of incubation, the medium was replaced with fresh medium. Following 24 h of growth in nonselective medium, cells were split into two plates and fed with medium containing G418 (400 mg/ml). Colonies were either isolated individually in separate plates or followed in the parent plates. This protocol worked efficiently on MCF.7 cells but not LA7 cells. For electroporation, 5 mg of BAC DNA was mixed with 1 Â 10 7 recipient cells in a 0.4 cm gap cuvette and pulsed at 300 V with 500 or 960 mF capacitance. Electroporated cells were plated in 100 mm tissue culture dishes in nonselective medium. After 24 h of expression time, the medium was replaced with selection medium containing G418.
Analysis of BAC transfer colonies
G418-resistant colonies appeared after 1-2 weeks. Thereafter, each colony was examined at regular intervals under a phase contrast microscope to assess colony morphology and to monitor growth. Cell doubling time was determined by counting cells under the microscope or in photomicrographs. Individual colonies were stained for senescence-specific acidic b-galactosidase using published procedure (Dimri et al., 1995) .
FISH
Biotin or digoxigenin-labeled probes made from BAC clones were hybridized to human metaphase chromosomes derived from PHA-stimulated peripheral blood cultures. The conditions of hybridizations, signal detection, digital-image acquisition, processing, and analysis, as well as the procedure for direct visualization of fluorescent signal to labeled chromosomes, were carried out as described previously (Zimonjic et al., 1995) .
